Sort
35,931 grants matching “parkinsons”
Development of a Microphysiological Organ-on-Chip System to Model Amyotrophic
$1,174,019Clive Niels Svendsen · Cedars-Sinai Medical Center · UH3 · FY2022 · NS
A Novel Instrument to Address Freezing of Gait in Parkinson's Patients
$1,173,858Brian R Clark · Barron Associates, Inc. · R44 · FY2025 · AG
Neurodegenerative Lysosomal Storage Disorders
$1,173,785Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
Chemically Modified Peptide Nucleic Acids
$1,173,550Daniel H Appella · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
THE NOSE KNOWS: HARNESSING HUMAN OLFACTORY CELLS TO IDENTIFY BIOMARKERS OF NONMOTOR CHANGES IN PARKINSON'S DISEASE
$1,173,445The Council Of The Queensland Institute Of Medical Research · · FY2024 · Defense Health Agency
Protein Misfolding and Aggregation
$1,171,998Jennifer Lee · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
THE GENETICS OF PARKINSONISM
$1,171,741Duke University · P50 · FY2003 · NS
Clinical Outcome Assessment and Treatment Monitoring Markers for Clinical Trial Readiness in FXTAS
$1,169,064David R Hessl · University Of California At Davis · U01 · FY2025 · NS
ICH Recovery Grant
$1,168,521Daniel Woo · University Of Cincinnati · R01 · FY2018 · NS
ICH Recovery Grant
$1,168,250Daniel Woo · University Of Cincinnati · R01 · FY2019 · NS
Molecular Engineering of Natural Light-Gated Chloride Channels for Optogenetic Inhibition
$1,167,224Mingshan Xue · Baylor College Of Medicine · U01 · FY2022 · NS
Molecular Engineering of Natural Light-Gated Chloride Channels for Optogenetic Inhibition
$1,167,224Mingshan Xue · Baylor College Of Medicine · U01 · FY2023 · NS
Trajectories and Markers of Neurodegeneration in Carriers of the Fragile X Premutation
$1,165,703David R Hessl · University Of California At Davis · R01 · FY2025 · NS
Role of molecular chaperones in protein folding diseases
$1,165,610Lois Greene · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
EMORY ALZHEIMERS DISEASE CENTER
$1,164,828Emory University · P30 · FY2000 · AG
Molecular Genetics Of Scrapie Pathogenesis
$1,164,826Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Disaggregation of Toxic Protein Oligomers in Brain with ElectromagneticTreatment
$1,164,576Gary W Arendash · Neuroem Therapeutics, Inc. · R44 · FY2021 · AG
Alpha Synuclein, cellular dysfunction and Parkinson disease
$1,164,387Mark Cookson · National Institute On Aging · ZIA · FY2022 · AG
NHGRI/DIR Technology Transfer Program
$1,164,158Claire Driscoll · National Human Genome Research Institute · ZIK · FY2014 · HG
Biomarkers of Catecholaminergic Neurodegeneration
$1,164,021David Goldstein · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Mechanistic Analysis of Genetic Modifiers in Parkinson's Disease
$1,164,000Dimitri Krainc · Northwestern University At Chicago · R35 · FY2024 · NS
A Lung-chip microphysiological system to model SARS-CoV-2 infection and test novel therapeutics
$1,163,750Clive Niels Svendsen · Cedars-Sinai Medical Center · UG3 · FY2020 · NS
MECHANISMS OF SPECIFIC LIPID-INDUCED DEGENERATION CAUSING NONMOTOR SYMPTOMS OF PARKINSON'S DISEASE. NEW AWARD.
$1,162,491The Mclean Hospital Corporation · · FY2020 · Department of the Army
A Randomized Recruitment Intervention
$1,162,338Barbara C Tilley · University Of Texas Hlth Sci Ctr Houston · U24 · FY2011 · MD
Prospective studies on Parkinson's disease
$1,161,245Honglei Chen · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES